ROYALTY PAYMENTS TO MILLENNIUM ON PRODUCTS Sample Clauses

ROYALTY PAYMENTS TO MILLENNIUM ON PRODUCTS. (a) Astra shall pay to Millennium royalties on Products that comprise a Program Small Molecule Drug or a Related Small Molecule Drug or a Program Peptido Mimetic Drug or a Related Peptido Mimetic Drug or a Program Antisense Drug or a Related Antisense Drug or a Program Protein Drug or a Program Analog Protein Drug or a Program Protein Mimic Drug. The royalties on each Product shall be payable initially at the rate of [**] of Net Sales, PROVIDED THAT, at such time as Net Sales for a Product in any calendar year exceed [**] then the royalty rate on all Net Sales of such Product in such calendar year (retroactive to the beginning of such year) and for all future calendar years shall be [**] of Net Sales of such Product, and PROVIDED FURTHER, that at such time as Net Sales for a Product in any calendar year exceed [**] then the royalty rate on all Net Sales of such Product in such calendar year (retroactive to the beginning of such year) and for all future calendar years shall be [**] of Net Sales of such Product.
Sample 1
AutoNDA by SimpleDocs
ROYALTY PAYMENTS TO MILLENNIUM ON PRODUCTS. In addition to the foregoing, with respect to each calendar quarter, Lilly shall pay to Millennium royalties equal to [**] of Net Sales of Products which are [**] of Net Sales of Products Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. which are [**] of Net Sales of Products which are either [**]; and [**] of Net Sales of Products which are [**] . Notwithstanding the terms of the prior paragraph, for any Products that are the result, to any extent, of research conducted by Millennium in a [**] with respect to which [**], conducted in accordance with [**] standards, then [**] of Net Sales of such products which are [**] , except as provided in the following paragraph;[**] of Net Sales of such products which are [**] of Net Sales of such products which are [**] of Net Sales of such products which are [**] . If the compound which is the basis of the [**] of Net Sales of such product. In addition, for any [**] that are the result, to any extent, of research conducted by Millennium in a [**] with respect to which [**] conducted in accordance with [**] standards capable of fulfilling such requirements for an [**] (or its equivalent) in any Major Market Country, then [**] of Net Sales of such products which are [**]. If the Joint Management Team decides that it is desirable to have a third party provide support on the Program (a "Third Party Collaborator"), and in an agreement between Lilly or Millennium and such Third Party Collaborator payment by either Millennium or Lilly of a royalty on the sale of Products is required, then Millennium and Lilly, at that time shall discuss in good faith whether an increase or decrease in the royalty on Net Sales of Products payable to Millennium under this Agreement is appropriate, and if agreed shall negotiate and agree to such an increase or decrease in royalty.
Sample 1

Related to ROYALTY PAYMENTS TO MILLENNIUM ON PRODUCTS

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Net Sales The term “

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount:

  • Royalties on Net Sales Novo will pay to Neose royalties as a percentage of annual Net Sales of each New Product during the Term at the applicable rates set forth in this Section 4.1 and in accordance with this Section 4:

  • Reports and Royalty Payments Within [* * *] days after the beginning of each Contract Quarter during the Royalty Term, Celgene shall deliver to Acceleron a report setting forth for the previous Contract Quarter the following information on a Licensed Product-by-Licensed Product and country-by-country basis in the Territory: (a) the gross sales and Net Sales of Licensed Product, (b) the number of units sold by Celgene, its Affiliates or Sublicensees, (c) the basis for any adjustments to the royalty payable for the sale of each Licensed Product, and (d) the royalty due hereunder for the sales of each Licensed Product (the “Royalty Report”). The total royalty due for the sale of Licensed Products during such Contract Quarter shall be remitted at the time such report is made. No such reports or royalty shall be due for any Licensed Product before the First Commercial Sale of such Licensed Product.

  • Royalty Rate Royalties shall be computed at the rate of six percent (6%) of Licensee's Net Sales during the applicable quarterly period.

  • Royalties 8.1 In consideration of the license herein granted, LICENSEE shall pay royalties to LICENSOR as follows:

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalty Rates Within [***] ([***]) [***] after the end of each calendar quarter, commencing with the calendar quarter during which the First Commercial Sale of a Licensed Product is made anywhere in the Territory and during the applicable Royalty Term, Hansoh shall make royalty payments to Viela based on Net Sales of all Licensed Products sold in the Territory in accordance with the table below. Within [***] ([***]) [***] after the end of each calendar quarter during the Term, Hansoh shall provide to Viela a report that contains the following information for the applicable calendar quarter, on a region-by-region basis: (i) the amount of Net Sales of such Licensed Product, (ii) a calculation of the royalty payment due on such Net Sales, including any royalty reduction made in accordance with Section 5.4(d), and (iii) the exchange rate used for converting any Net Sales recorded in a currency other than Dollars. In the case that the annualized royalty rate during a particular calendar year is more than that set forth in the table below, the corresponding overpayment received by Viela shall be credited to Hansoh against subsequent royalty payments; and in the case that the annualized royalty rate during a particular calendar year is less than that set forth in the table below, Hansoh shall pay the difference within [***] ([***]) [***] after receipt of Viela’s invoice. Threshold of the Net Sales of all Licensed Products Royalty % [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

Time is Money Join Law Insider Premium to draft better contracts faster.